Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 10:13 PM
Ignite Modification Date: 2025-12-24 @ 10:13 PM
NCT ID: NCT03117335
Eligibility Criteria: Inclusion Criteria: 1. Male and female aged 18 to 70 years old; 2. Patients with histological confirmed stage IV NSCLC; 3. According to the standard of RECIST1.1, they should have at least one of accurately measurable lesions with the largest diameter \>=10mm by spiral CT, PET-CT, with the largest diameter \>=20mm by ordinary CT and MRI; 4. general condition ECOG performance scale (PS) 0-1; 5. Life expectancy of more than 3 months; 6. No major organ dysfunction and laboratory indicators should meet the following requirements: absolute neutrophil count \> 1.5\*10\^9/L, platelet count\> 90\*10\^9/L, hemoglobin\> 9g/dL; liver function: serum bilirubin was less than 2\* maximum normal value; ALT and AST were less than 2.5\*maximum normal value; BUN, Cr within 80% of normal range; 7. Patients could understand the circumstances of this study and those who have signed the informed consent form. Exclusion Criteria: 1. Receive the treatment of other experimental trials in the same period; on the medication of other anticancer drugs at the same time; 2. Patients who have uncontrolled brain metastasis; 3. Suffered from any other malignant tumors in the five years except for complete cure of cervical carcinoma in situ, basal cell cancer; 4. Pregnant or lactating women; 5. Severe infected patients; 6. Patients who have serious cardiovascular disease such as coronary heart disease, unstable cardiac angina and high blood pressure; 7. Patients who have vein thrombus; 8. Patients who have psychiatric illness; 9. Patients who are allergic to E. coli preparation; 10. Researchers believe that those who do not fit.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 70 Years
Study: NCT03117335
Study Brief:
Protocol Section: NCT03117335